Design and Development of Drugs for Alzheimer’s Dementia as a Protein Misfolding Disorder

Canadian Journal of Neurological Sciences - United Kingdom
doi 10.1017/cjn.2015.95
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Hybrid Design as a Strategy for Development of Trypanocidal Drugs

Journal of Pharmaceutical Research International
2019English

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases

Brain Sciences
Neuroscience
2017English

Protein Markers for the Differential Diagnosis of Vascular Dementia and Alzheimer’s Disease

International Journal of Proteomics
BiochemistryMolecular Biology
2012English

"Alzheimer’s Dementia "

Hospice and Palliative Medicine International Journal
2018English

Preventing Alzheimer’s Dementia

British Medical Journal
Medicine
2017English

Protein Misfolding Diseases

The Open Biology Journal
2009English

Oscillatory Connectivity as a Diagnostic Marker of Dementia Due to Alzheimer’s Disease

Clinical Neurophysiology
Sensory SystemsNeurologyPhysiology
2019English

Natural Products for the Therapy of Proteinopathies Underlying the Neurodegenerative Conditions: Protein Misfolding and Fibrillization in Alzheimer’s Disease and Parkinson’s Disease

American Journal of Biomedical Science & Research
2019English

Principal Component Analysis of Brain Metabolism Predicts Development of Alzheimer’s Dementia

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy